1Badsha H, Kong KO, Lian TY, et al. Low-dose pulse methylprednisolone for systemic lupus Erythematosus flares is efficacious and has a decreased risk of infectious complications[J]. Lupus,2002, 11:508 -513.
2Boumpas DT, Austin HA, Vaughn EM, et al. Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis[ J]. Lancet, 1992 ; 340: 741 -745.
3Abu-Shakra M, Shoenfeld Y. Azathioprine therapy for patients with systemic lupus erythematosus[ J]. Lupus, 2001, 10:152 -153.
4American college of rheumatology Ad Hoc committee on systemic lupus erythrmatesus guidelines. Guidelines for referral and management of systemic lupus erythematosus in adults[J]. Arthritis Rheum, 1999, 42:1785 -1796.
5Boumpas DT, Austin HA, Vaughan EM, et al. Risk for sustained amenorrhea in patients with sustemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy [ J ]. Ann Intern Med, 1993, 119 : 366 - 369.
6Takada K, IUei GG, Boumpas DT. Cyclophosphamide for the treatment of systemic lupus erythematosus[ J ]. Lupus, 2001, 10: 154-161.
7Illei GG, Austin HA, Crane M, et al. Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis[ J ]. Ann Imtern Med, 2001, 135:248 -257.
8Houssiau FA, Vasconcelos C, D' Cruz D, et al. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low- dose versus high- dose intravenous cyclophosphamide [ J ]. Arthritis Rheum, 2002, 46:2121 -2131.
9Stojanovich L, Stojanovich R, Kostich V, et al. Neuropsychiatric lupus favourable response to low dose i. v. cyclophosphamide and predniselone(pilot study) [J]. Lupus, 2003, 12:3 -7.
1Boumpas DT,Austin HA,Vaughn EM,et al.Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis.Lancet,1992,340:741-745.
2Gourley MF,Austin HA,Scott D,et al.Methylprednisolone and cyclophosphamide,alone or in combination,in patients with lupus nephritis.Ann Intern Med,1996,125:549-557.
3Illei GG,Austin HA,Crane M,et al.Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis.Ann Intern Med,2001,135:248-257.
4Austin HA,Klippel JH,Balow JE,et al.Therapy of lupus nephritis:controlled trial of prednisolone and cytotoxic drugs.New Engl J Med,1986,314:614-619.
5Gorman C,Bhatia A,Rahman A.This house believes that lowdose intravenous cyclophosphamide is superior to standard highdose regimens for treatment of lupus nephritis.Rheumatology,2005,44:398-401.
6Houssiau FA,Vasconcelos C,D'Cruz D,et al.Immunosuppressive therapy in lupus nephritis.Arthritis Rheum,2002,46:2121-2131.
7Martin-Suarez I,D'Cruz D,Mansoor M,et al.Immunosuppressive treatment in severe connective tissue diseases:effects of low dose intravenous cyclophosphamide.Ann Rheum Dis,1997,56:481-487.
